BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

979 related articles for article (PubMed ID: 24073714)

  • 1. Idiosyncratic drug-induced liver injury: an update on the 2007 overview.
    Hussaini SH; Farrington EA
    Expert Opin Drug Saf; 2014 Jan; 13(1):67-81. PubMed ID: 24073714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug-induced liver injury: what was new in 2013?
    Chalhoub WM; Sliman KD; Arumuganathan M; Lewis JH
    Expert Opin Drug Metab Toxicol; 2014 Jul; 10(7):959-80. PubMed ID: 24746272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug-induced liver injury: a safety review.
    García-Cortés M; Ortega-Alonso A; Lucena MI; Andrade RJ;
    Expert Opin Drug Saf; 2018 Aug; 17(8):795-804. PubMed ID: 30059261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug-induced liver injury.
    Leise MD; Poterucha JJ; Talwalkar JA
    Mayo Clin Proc; 2014 Jan; 89(1):95-106. PubMed ID: 24388027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Idiosyncratic drug-induced liver injury: an overview.
    Hussaini SH; Farrington EA
    Expert Opin Drug Saf; 2007 Nov; 6(6):673-84. PubMed ID: 17967156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacogenetic testing in idiosyncratic drug-induced liver injury: current role in clinical practice.
    Aithal GP
    Liver Int; 2015 Jul; 35(7):1801-8. PubMed ID: 25809692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An update on drug induced liver injury.
    Rangnekar AS; Fontana RJ
    Minerva Gastroenterol Dietol; 2011 Jun; 57(2):213-29. PubMed ID: 21587150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Top-ranking drugs out of 3312 drug-induced liver injury cases evaluated by the Roussel Uclaf Causality Assessment Method.
    Teschke R
    Expert Opin Drug Metab Toxicol; 2018 Nov; 14(11):1169-1187. PubMed ID: 30354694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-induced liver injury: an overview over the most critical compounds.
    Björnsson ES
    Arch Toxicol; 2015 Mar; 89(3):327-34. PubMed ID: 25618544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug induced liver injury: an update.
    Garcia-Cortes M; Robles-Diaz M; Stephens C; Ortega-Alonso A; Lucena MI; Andrade RJ
    Arch Toxicol; 2020 Oct; 94(10):3381-3407. PubMed ID: 32852569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenesis of idiosyncratic drug-induced liver injury and clinical perspectives.
    Fontana RJ
    Gastroenterology; 2014 Apr; 146(4):914-28. PubMed ID: 24389305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review article: drug-induced liver injury in clinical practice.
    Björnsson E
    Aliment Pharmacol Ther; 2010 Jul; 32(1):3-13. PubMed ID: 20374223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence, presentation, and outcomes in patients with drug-induced liver injury in the general population of Iceland.
    Björnsson ES; Bergmann OM; Björnsson HK; Kvaran RB; Olafsson S
    Gastroenterology; 2013 Jun; 144(7):1419-25, 1425.e1-3; quiz e19-20. PubMed ID: 23419359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-Induced liver injury with hypersensitivity features has a better outcome: a single-center experience of 39 children and adolescents.
    Devarbhavi H; Karanth D; Prasanna KS; Adarsh CK; Patil M
    Hepatology; 2011 Oct; 54(4):1344-50. PubMed ID: 21735470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive analysis and insights gained from long-term experience of the Spanish DILI Registry.
    Stephens C; Robles-Diaz M; Medina-Caliz I; Garcia-Cortes M; Ortega-Alonso A; Sanabria-Cabrera J; Gonzalez-Jimenez A; Alvarez-Alvarez I; Slim M; Jimenez-Perez M; Gonzalez-Grande R; Fernández MC; Casado M; Soriano G; Román E; Hallal H; Romero-Gomez M; Castiella A; Conde I; Prieto M; Moreno-Planas JM; Giraldez A; Moreno-Sanfiel JM; Kaplowitz N; Lucena MI; Andrade RJ;
    J Hepatol; 2021 Jul; 75(1):86-97. PubMed ID: 33539847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Approaches to the study of drug-induced liver injury.
    Fontana RJ
    Clin Pharmacol Ther; 2010 Sep; 88(3):416-9. PubMed ID: 20664536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting and preventing acute drug-induced liver injury: what's new in 2010?
    Liss G; Rattan S; Lewis JH
    Expert Opin Drug Metab Toxicol; 2010 Sep; 6(9):1047-61. PubMed ID: 20615079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting idiosyncratic drug-induced liver injury: some recent advances.
    Chen M; Borlak J; Tong W
    Expert Rev Gastroenterol Hepatol; 2014 Sep; 8(7):721-3. PubMed ID: 24857265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse drug reactions and organ damage: The liver.
    Licata A
    Eur J Intern Med; 2016 Mar; 28():9-16. PubMed ID: 26827101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A closer look at the spectrum of drug-induced liver injury in sub-Saharan Africa.
    Riebensahm C; Ka D; Sow A; Semmo N; Wandeler G
    Expert Rev Clin Pharmacol; 2019 Sep; 12(9):875-883. PubMed ID: 31269818
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 49.